Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.
P. Braitstein,M. Brinkhof,12 Authors,M. Egger
2006 · DOI: 10.1016/S0140-6736(06)68337-2
The Lancet · 1,165 Citations
TLDR
Patients starting HAART in resource-poor settings have increased mortality rates in the first months on therapy, compared with those in developed countries, and timely diagnosis and assessment of treatment eligibility, coupled with free provision of HAART might reduce this excess mortality.